(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BEGESAND

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BEGESAND

ST13

US500000079201532

Class

5, 10

Filing

79201532

Registration

5372122

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

07/12/2025

Trademark type

Word

Nice classes

5, 10

Filing date

09/08/2016

Registration date

01/09/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/26/2024

Last transaction

07/12/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

33

Owner location

CH

Examiner

TWOHIG,SHANNON MARIE

Law office

N20

Current location

TMO LAW OFFICE 120

Holders and representatives

Holders

ADIENNE SA

Representatives

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorders; medical preparations for the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorders; and veterinary preparations for the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food for treating viral and infectious diseasesfor treating cancerfor treating immune system related diseases and disordersfor the prevention and treatment of cancersubstances in the nature of beverages for medical or veterinary use; monoclonal antibodies and antibody mixtures for medical usediagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; monoclonal antibodies for immunomodulatory treatmentsin particular for the treatment of diseases mediated by the differentiation cluster 26 molecule CD26; pharmaceutical preparations comprising as active ingredient monoclonal antibodies having immunomodulatory effectsin particular for the treatment of diseases mediated by the 26 differentiation cluster molecule CD26; dietetic foodsyogurt and rice-derived productsrice flour adapted for medical usedietetic beverages adapted for medical usefood supplementsenzyme food supplementsprotein food supplementsprotein supplements for animalsby-products of the processing of cereals for dietetic or medical usebiological preparations for medical usebiological preparations for veterinary usepills for medicinesimmunosuppressant pillschemical preparations for medical usefor the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorderschemical preparations for veterinary usefor the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disordersbiological tissue cultures for medical usebiological tissue cultures for veterinary useenzyme preparations for medical useenzyme preparations for veterinary useenzymes for medical useenzymes for veterinary usemedicines for veterinary use for the treatment of viral and infectious diseasesfor the treatment of cancerfor the treatment of immune system related diseases and disordersfor the prevention and treatment of cancerremedies for veterinary usemonoclonal antibodies for immunomodulatory treatmentsvaccinesveterinary products in the nature of anti-infective products for veterinary use; living tissue graftssurgical implants composed of living tissueradiological contrast substances for medical usediagnostic preparations for medical usebiomarker reagents for diagnosis for medical useadjuvants for medical usechemical preparations for pharmaceutical usedrugs for medical usefor the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorderspharmaceutical preparationselixirs for treating viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disordersplant extracts for pharmaceutical usemedicinal infusions for treating viral and infectious diseasesfor treating cancerfor treating immune system related diseases and disordersfor the prevention and treatment of cancerlotions for pharmaceutical usemedicines or human medicine for the treatment of viral and infectious diseasesfor the treatment of cancerfor the treatment of immune system related diseases and disordersfor the prevention and treatment of cancerremedies for human medicine in the nature of solution for injection for the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorderspharmaceutical preparations for skin carepharmaceutical preparations for the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorderssyrups for pharmaceutical use for the treatment of viral and infectious diseasesfor the treatment of cancerfor the prevention and treatment of cancerfor the treatment of immune system related diseases and disorders

Class 10

Surgicalmedicaldental and veterinary apparatus and instrumentsinfusion bagvialsyringe; needles for medical usemedical apparatus and instrumentscontainers for applying medicinesinfusion bagvialsyringehypodermic syringessyringes for medical usepumps for medical useinfusion pump

Publications

History of USPTO decisions and trademark events.

34 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

07/11/2025

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

06/24/2025

INPC

INVALIDATION PROCESSED

06/24/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

03/26/2025

C71T

CANCELLED SECTION 71

07/26/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/09/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/31/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/01/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/16/2018

FIMP

FINAL DISPOSITION PROCESSED

04/16/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/09/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

01/09/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/24/2017

PUBO

PUBLISHED FOR OPPOSITION

10/24/2017

GPNX

NOTIFICATION PROCESSED BY IB

10/21/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/04/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/04/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/19/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/29/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/29/2017

ALIE

ASSIGNED TO LIE

08/23/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/02/2017

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/24/2017

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/24/2017

RFNT

REFUSAL PROCESSED BY IB

03/18/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/28/2017

RFRR

REFUSAL PROCESSED BY MPU

02/28/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/25/2017

CNRT

NON-FINAL ACTION WRITTEN

02/24/2017

MAFR

APPLICATION FILING RECEIPT MAILED

02/21/2017

DOCK

ASSIGNED TO EXAMINER

02/17/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/17/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/16/2017

Continuous trademark protection

Get notified about every new filing that threatens BEGESAND or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.